Anaplastic Lymphoma Kinase Positive Non-Small Cell Lung Cancer

Details

Files

Project Status:

Complete

Therapeutic Area:

ALK-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer

Project Line:

Reimbursement Review

Project Sub Line:

Provisional Funding Algorithm

Project Number:

PH0009-000

Review Type: Rapid

Provisional Funding Algorithm
Draft Report Posted	March 24, 2022
Stakeholder Feedback Deadline	April 07, 2022
Final Report Posted	May 24, 2022

Last Updated : May 24, 2022